查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511260

到 2030 年雄性脫髮症市場預測：按治療類型、藥物類型、給藥管道、通路、最終用戶和地區進行的全球分析

Androgenetic Alopecia Treatment Market Forecasts to 2030 - Global Analysis By Treatment Type, Medication Type, Route of Administration, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球男性型脫髮症治療市場規模將達到 30 億美元，預計到 2030 年將達到 53 億美元，預測期內複合年成長率為 9.6%。男性型脫髮症治療旨在控制由遺傳和荷爾蒙因素引起的脫髮，主要影響男性和女性。有幾種方法可以促進頭髮生長並防止進一步脫髮，包括米諾地爾和Finasteride等藥物治療。頭髮移植手術等外科手術也很常見，即將健康的毛囊移植到禿頭區域。此外，生活方式的改變，如減輕壓力和均衡飲食，可以補充這些治療方法，並對男性脫髮症提供更全面的效果。

根據《臨床與診斷研究雜誌》(JCDR) 的一項研究，大約 60% 的人口患有脫髮，多種因素導致男性和女性脫髮的嚴重程度。

雄性脫髮症的盛行率不斷增加

男性型脫髮症的日益普及對市場產生了重大影響。隨著越來越多的人受到這種情況的影響，對有效治療方法和解決方案的需求不斷增加。這一趨勢刺激了市場的創新和研究，導致了先進治療方法和產品的開發，以滿足受雄性脫髮症影響的個人的特定需求。市場擴張反映了人們對脫髮管理和恢復的認知和重視程度的提高。

副作用和安全問題

副作用和安全問題是這個市場的主要問題。患者可能會遇到米諾地爾等外用藥物的副作用，例如頭皮發炎、乾燥和髮質改變。Finasteride等內服藥物引起了人們對潛在性副作用的擔憂。這些挑戰凸顯了研究和開發更安全、更有效的治療方法的重要性。

對有效治療的需求不斷成長

市場對有效治療的需求大幅增加。這是由於意識增強、生活方式改變和人口老化等因素造成的。消費者正在尋求創新的解決方案來有效解決脫髮問題，並且市場快速成長，有機會提供新穎的治療方法和產品來滿足這一需求。

缺乏意識

許多脫髮患者並不完全了解他們管理和治療脫髮的選擇，這可能導致治療延遲或不足。這種認知的缺乏延伸到了醫療保健提供者，影響了他們為雄性脫髮症患者提供全面指導和支持的能力。該市場的一個主要挑戰是公眾對可用解決方案及其有效性缺乏認知。

COVID-19 的影響：

COVID-19 的疫情對男性型脫髮症治療市場產生了重大影響。由於封鎖和限制，許多提供脫髮治療的診所面臨關閉或容量減少，導致患者就診和治療程序減少。供應鏈中斷也影響了脫髮治療和治療方法的可用性。然而，由於遠端醫療諮詢的引入以及疫情後醫療服務的逐步恢復，市場正顯示出韌性。

毛髮移植領域預計在預測期內規模最大

預計毛髮移植領域在預測期內規模最大。此治療市場的技術和程序的進步顯著改善了治療結果和患者滿意度。由於意識的提高、負擔能力的提高以及對更自然外觀的渴望等因素，對毛髮移植手術的需求持續增加。隨著越來越多的人尋求有效的脫髮解決方案，這一趨勢預計將持續下去。

皮膚科診所預計在預測期內複合年成長率最高

預計皮膚科診所領域在預測期內的複合年成長率最高。在這些診所，皮膚科醫師進行診斷並開立個人化治療方案，包括局部和內服藥物藥物以及 PRP 治療和植髮等高階手術。我們還提供全面的諮詢和持續監測，以滿足每位患者的獨特需求，為治療市場的擴張做出了重大貢獻。

比最大的地區

預計北美在預測期內將佔據最大的市場佔有率。隨著患者尋求更有效、侵入性更小的解決方案，頭髮再生領域的技術進步（例如雷射治療設備和幹細胞治療）正在促進市場成長。市場競爭激烈，製藥公司、醫療設備製造商和專科診所透過提供創新產品和服務來爭奪市場佔有率。

複合年成長率最高的地區：

由於脫髮治療意識的提高、醫療技術的進步以及可支配收入的增加等因素，預計亞太地區在預測期內將保持最高的複合年成長率。印度、中國和日本等國家對脫髮解決方案（包括藥物療法、治療方法和手術）的需求激增。市場的主要參與企業正在專注於開發創新產品，以滿足不斷成長的需求並增加市場影響。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 按產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行概述

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球雄性脫髮症市場：依治療類型

  • 介紹
  • 局部治療
  • 口服藥物
  • 植髮
  • 低功率雷射治療 (LLLT)
  • 其他

第6章全球雄性脫髮症治療市場：依藥物類型

  • 介紹
  • 5-α還原酶抑制劑（5ARI）
  • 米諾地爾
  • Finasteride
  • 度他雄胺
  • 其他

第7章全球雄性脫髮症治療市場：依給藥途徑

  • 介紹
  • 局部解決方案
  • 注射治療
  • 口服
  • 植入

第8章全球雄性脫髮症市場：按分銷管道

  • 介紹
  • 藥局
  • 網路零售
  • 專科診所
  • 醫院

第9章全球雄性脫髮症市場：依最終用戶分類

  • 介紹
  • 居家醫療
  • 皮膚科診所
  • 製藥
  • 其他

第10章全球雄性脫髮症市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Merck & Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Bayer AG
  • GlaxoSmithKline
  • Allergan
  • Histogen Inc.
  • Dr. Reddy's Laboratories
  • Cipla Limited
  • Aclaris Therapeutics
  • Anterios, Inc.
  • Aurora Scalp Clinics
  • Shiseido
  • Histogenics Corporation
  • Regenera Activa
  • Sun Pharmaceutical Industries Ltd.
Product Code: SMRC26630

According to Stratistics MRC, the Global Androgenetic Alopecia Treatment Market is accounted for $3.0 billion in 2024 and is expected to reach $5.3 billion by 2030 growing at a CAGR of 9.6% during the forecast period. Androgenetic alopecia treatment aims to manage hair loss caused by genetic and hormonal factors, primarily affecting men and women. It encompasses various approaches, including medications like minoxidil and finasteride, which promote hair growth and prevent further loss. Surgical options like hair transplant surgery are also common, involving the relocation of healthy hair follicles to balding areas. Additionally, lifestyle changes, such as stress reduction and a balanced diet, complement these treatments for more comprehensive results in combating androgenetic alopecia.

According to The Journal of Clinical and Diagnostic Research (JCDR)'s study, roughly 60% of the population suffers from hair loss, with various factors contributing to the severity of pattern hair loss in both sexes.

Market Dynamics:

Driver:

Increasing prevalence of androgenetic alopecia

The increasing prevalence of androgenetic alopecia has significantly impacted the market. As more individuals are affected by this condition, there's a growing demand for effective treatments and solutions. This trend has spurred innovation and research within the market, leading to the development of advanced therapies and products tailored to address the specific needs of individuals experiencing androgenetic alopecia. The market's expansion reflects the rising awareness and emphasis on hair loss management and restoration.

Restraint:

Side effects and safety concerns

In the market, side effects and safety concerns pose significant challenges. Patients may experience adverse reactions such as scalp irritation, dryness, or changes in hair texture with topical medications like minoxidil. Oral medications like finasteride have raised concerns about potential sexual side effects. These challenges underscore the importance of ongoing research and development for safer, more effective treatments.

Opportunity:

Growing demand for effective treatments

The market is experiencing a significant surge in demand for effective treatments. This is driven by factors such as increasing awareness, changing lifestyle patterns, and a growing aging population. Consumers are seeking innovative solutions that can effectively address hair loss concerns, leading to a burgeoning market with opportunities for novel therapies and products to cater to this demand.

Threat:

Lack of awareness

Many individuals affected by this condition may not fully understand the options for managing or treating it, leading to delayed or inadequate treatment. This lack of awareness also extends to healthcare providers, impacting their ability to offer comprehensive guidance and support to patients dealing with androgenetic alopecia. In the market, a significant challenge is the lack of awareness among the general population regarding available solutions and their effectiveness.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the Androgenetic Alopecia Treatment market. Due to lockdowns and restrictions, many clinics offering hair loss treatments faced closures or reduced capacity, leading to a decline in patient visits and treatment procedures. Supply chain disruptions also affected the availability of hair loss medications and therapies. However, the market has shown resilience with the adoption of telemedicine for consultations and the gradual recovery of healthcare services post-pandemic.

The hair transplantation segment is expected to be the largest during the forecast period

The hair transplantation segment is expected to be the largest during the forecast period. In the market for this treatment, advancements in technology and techniques have significantly improved outcomes and patient satisfaction. The demand for hair transplantation procedures continues to rise, driven by factors such as increasing awareness, improved affordability, and the desire for a more natural appearance. This trend is expected to persist as more individuals seek effective solutions for hair loss.

The dermatology clinics segment is expected to have the highest CAGR during the forecast period

The dermatology clinics segment is expected to have the highest CAGR during the forecast period. These clinics employ dermatologists who diagnose and prescribe personalized treatments such as topical medications, oral medications, and advanced procedures like PRP therapy or hair transplants. They also provide comprehensive consultations and ongoing monitoring to address the unique needs of each patient, contributing significantly to the growing market for the treatments.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. Technological advancements in the field of hair restoration, such as laser therapy devices and stem cell treatments, contribute to the growth of the market as patients seek more effective and minimally invasive solutions. The market is competitive, with pharmaceutical companies, medical device manufacturers, and specialized clinics vying for market share by offering innovative products and services.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period driven by factors such as increasing awareness about hair loss treatments, advancements in medical technologies, and rising disposable incomes. Countries like India, China, and Japan are witnessing a surge in demand for hair loss solutions, including medications, therapies, and surgical procedures. Key players in the market are focusing on developing innovative products to cater to this growing demand and enhance their market presence in the region.

Key players in the market

Some of the key players in Androgenetic Alopecia Treatment market include Merck & Co., Inc., Johnson & Johnson, Pfizer Inc., Bayer AG, GlaxoSmithKline, Allergan, Histogen Inc., Dr. Reddy's Laboratories, Cipla Limited, Aclaris Therapeutics, Anterios, Inc., Aurora Scalp Clinics, Shiseido, Histogenics Corporation, Regenera Activa and Sun Pharmaceutical Industries Ltd.

Key Developments:

In December 2023, Sun Pharmaceutical Industries Ltd. entered into a strategic collaboration with Aclaris. Sun Pharma will get exclusive rights for the use of deuruxolitinib JAK inhibitor or other isotopic forms of ruxolitinib used to treat alopecia areata and androgenetic alopecia

In June 2023, Dr. Reddy's Laboratories Ltd. announced an expansion of its generics business in India with the launch of RgenX. This dedicated division offers a wider range of affordable products to patients

In June 2023, Pfizer, Inc. received the U.S. FDA approval of Litfulo (ritlecitinib) to treat hair loss caused by alopecia. The drug blocks inflammatory signals that increase hair loss

Treatment Types Covered:

  • Topical Treatments
  • Oral Medications
  • Hair Transplantation
  • Low-Level Laser Therapy (LLLT)
  • Other Treatment Types

Medication Types Covered:

  • 5-alpha Reductase Inhibitors (5ARIs)
  • Minoxidil
  • Finasteride
  • Dutasteride
  • Other Medication Types

Route of Administrations Covered:

  • Topical Solutions
  • Injectable Treatments
  • Oral
  • Implants

Distribution Channels Covered:

  • Drug Stores
  • Online Retail
  • Specialty Clinics
  • Hospitals

End Users Covered:

  • Homecare Settings
  • Dermatology Clinics
  • Pharmaceutical
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Androgenetic Alopecia Treatment Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Topical Treatments
  • 5.3 Oral Medications
  • 5.4 Hair Transplantation
  • 5.5 Low-Level Laser Therapy (LLLT)
  • 5.6 Other Treatment Types

6 Global Androgenetic Alopecia Treatment Market, By Medication Type

  • 6.1 Introduction
  • 6.2 5-alpha Reductase Inhibitors (5ARIs)
  • 6.3 Minoxidil
  • 6.4 Finasteride
  • 6.5 Dutasteride
  • 6.6 Other Medication Types

7 Global Androgenetic Alopecia Treatment Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Topical Solutions
  • 7.3 Injectable Treatments
  • 7.4 Oral
  • 7.5 Implants

8 Global Androgenetic Alopecia Treatment Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Drug Stores
  • 8.3 Online Retail
  • 8.4 Specialty Clinics
  • 8.5 Hospitals

9 Global Androgenetic Alopecia Treatment Market, By End User

  • 9.1 Introduction
  • 9.2 Homecare Settings
  • 9.3 Dermatology Clinics
  • 9.4 Pharmaceutical
  • 9.5 Other End Users

10 Global Androgenetic Alopecia Treatment Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Merck & Co., Inc.
  • 12.2 Johnson & Johnson
  • 12.3 Pfizer Inc.
  • 12.4 Bayer AG
  • 12.5 GlaxoSmithKline
  • 12.6 Allergan
  • 12.7 Histogen Inc.
  • 12.8 Dr. Reddy's Laboratories
  • 12.9 Cipla Limited
  • 12.10 Aclaris Therapeutics
  • 12.11 Anterios, Inc.
  • 12.12 Aurora Scalp Clinics
  • 12.13 Shiseido
  • 12.14 Histogenics Corporation
  • 12.15 Regenera Activa
  • 12.16 Sun Pharmaceutical Industries Ltd.

List of Tables

  • Table 1 Global Androgenetic Alopecia Treatment Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Androgenetic Alopecia Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 3 Global Androgenetic Alopecia Treatment Market Outlook, By Topical Treatments (2022-2030) ($MN)
  • Table 4 Global Androgenetic Alopecia Treatment Market Outlook, By Oral Medications (2022-2030) ($MN)
  • Table 5 Global Androgenetic Alopecia Treatment Market Outlook, By Hair Transplantation (2022-2030) ($MN)
  • Table 6 Global Androgenetic Alopecia Treatment Market Outlook, By Low-Level Laser Therapy (LLLT) (2022-2030) ($MN)
  • Table 7 Global Androgenetic Alopecia Treatment Market Outlook, By Other Treatment Types (2022-2030) ($MN)
  • Table 8 Global Androgenetic Alopecia Treatment Market Outlook, By Medication Type (2022-2030) ($MN)
  • Table 9 Global Androgenetic Alopecia Treatment Market Outlook, By 5-alpha Reductase Inhibitors (5ARIs) (2022-2030) ($MN)
  • Table 10 Global Androgenetic Alopecia Treatment Market Outlook, By Minoxidil (2022-2030) ($MN)
  • Table 11 Global Androgenetic Alopecia Treatment Market Outlook, By Finasteride (2022-2030) ($MN)
  • Table 12 Global Androgenetic Alopecia Treatment Market Outlook, By Dutasteride (2022-2030) ($MN)
  • Table 13 Global Androgenetic Alopecia Treatment Market Outlook, By Other Medication Types (2022-2030) ($MN)
  • Table 14 Global Androgenetic Alopecia Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 15 Global Androgenetic Alopecia Treatment Market Outlook, By Topical Solutions (2022-2030) ($MN)
  • Table 16 Global Androgenetic Alopecia Treatment Market Outlook, By Injectable Treatments (2022-2030) ($MN)
  • Table 17 Global Androgenetic Alopecia Treatment Market Outlook, By Oral (2022-2030) ($MN)
  • Table 18 Global Androgenetic Alopecia Treatment Market Outlook, By Implants (2022-2030) ($MN)
  • Table 19 Global Androgenetic Alopecia Treatment Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 20 Global Androgenetic Alopecia Treatment Market Outlook, By Drug Stores (2022-2030) ($MN)
  • Table 21 Global Androgenetic Alopecia Treatment Market Outlook, By Online Retail (2022-2030) ($MN)
  • Table 22 Global Androgenetic Alopecia Treatment Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 23 Global Androgenetic Alopecia Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 24 Global Androgenetic Alopecia Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 25 Global Androgenetic Alopecia Treatment Market Outlook, By Homecare Settings (2022-2030) ($MN)
  • Table 26 Global Androgenetic Alopecia Treatment Market Outlook, By Dermatology Clinics (2022-2030) ($MN)
  • Table 27 Global Androgenetic Alopecia Treatment Market Outlook, By Pharmaceutical (2022-2030) ($MN)
  • Table 28 Global Androgenetic Alopecia Treatment Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.